Switching from finasteride to dutasteride caused significant shedding but minimal side effects. The user plans to continue dutasteride for 12 months despite concerns about hair density.
AH-001 is a new topical treatment designed to degrade androgen receptors, targeting the root cause of androgenetic alopecia without the side effects of oral treatments like finasteride. It has shown a strong safety profile and good local tolerability in early trials.
A 19-year-old male shared progress pictures showing hair regrowth on his scalp after starting a treatment with Minoxidil and Finasteride on November 24th. He noted improved hair texture and a halt in hair shedding for the past two weeks.
A man in his early 30s noticing hair thinning, mainly on the crown of his head. He's been using 1mg oral finasteride and keto shampoo daily for 4 months, with noticeable improvement and no side effects.
A user's 6 month progress using finasteride and minoxidil as treatments for hair loss, with the replies discussing side effects and general consensus about usage of the two medications.
User shared progress pictures of hair density improvement using 1mg finasteride and topical minoxidil, but expressed concern about recent hairline miniaturization and treatment effectiveness. Another user complimented the results and inquired about initial shedding.
The conversation discusses patient updates on hair loss treatment with Verteporfin after five months, as reported by Dr. Blake Bloxham. Patients voluntarily sent their progress pictures to Dr. Bloxham.
Lab-grown hair using iPSCs is being explored, but practical applications are limited. Finasteride is suggested as the only current effective treatment.
A user shared their 13-month hair regrowth results using Finasteride 0.25mg three times a week, Biotin, Nizoral, Vitamin D, and a multivitamin. Commenters discussed the effectiveness of low-dose Finasteride and inquired about potential side effects and the addition of Minoxidil.
Using Dutasteride as a hair loss treatment and its potential benefits, including availability in certain countries without a prescription and lower side effects than Minoxidil or RU58841.
A user shared before and after photos 24 months after a hair transplant, but others accused the photos of being fake and airbrushed. One user mentioned that having a beard hair transplant with androgenetic alopecia is a bad idea.
The user reported slight hair improvement using dietary changes, Nizoral shampoo, microneedling, and rosemary oil massages. They avoided medications like minoxidil and finasteride due to side effects concerns.
A user shared progress pictures after using 1 mg finasteride and topical minoxidil for six months, hoping for further improvement by the one-year mark. The user reported no side effects and uses Head & Shoulders shampoo.
The potential accuracy and trustworthiness of websites selling Pyrilutamide, a drug related to hair loss treatments such as Minoxidil, Finasteride, and RU58841; and whether Pyrilutamide is four times stronger than RU58841.
The user shared progress pictures showing hair improvement over four months using 1 mg finasteride and 5 mg minoxidil daily. They reported no significant side effects and plan to reduce the minoxidil dose once satisfied with the results.
Koshine 826 (Pyrilutamide) has mixed reviews, with some users experiencing side effects like insomnia and others seeing minimal results. Concerns about the company's transparency and lack of progress photos are noted.
A dutasteride simulator predicts that daily 0.5 mg dosing results in higher DHT suppression compared to less frequent dosing. Twice-weekly dutasteride may be as effective as finasteride 5 mg, providing a balance between efficacy and ease of use.
PP405 is a new hair loss treatment targeting dormant hair follicles, with ongoing trials. Some users consider stopping finasteride and minoxidil to join trials, while others doubt its effectiveness.
Finasteride and Dutasteride will remain accessible in the EU despite objections from France and Belgium. Users discuss the ease of obtaining these medications in different countries and express relief and support for the EU's decision.
The conversation discusses using topical Calcipotriol and Valproic Acid for hair loss, focusing on their mechanisms involving the VDR receptor and Wnt/beta-catenin pathway. Specific treatments mentioned are Minoxidil, Finasteride, and RU58841.
The user shared progress pictures showing hair improvement after using Minoxidil for eight months and then adding Finasteride, noting no dramatic change but some improvement. The user experienced a shed after starting Minoxidil but not after adding Finasteride, and reported no side effects from Finasteride.
The conversation discusses the impact of hair loss treatments like dutasteride and finasteride, with some users expressing skepticism about media claims linking these drugs to severe side effects like suicidal ideation. Many participants criticize the media, particularly British tabloids, for fearmongering and emphasize the psychological impact of hair loss itself.
A user's six-month update on their hair loss treatment plan, which includes topical finasteride and minoxidil, dermarolling, and ketokonazole. Replies to the post appreciate the comparison pictures and commend the results achieved from the treatments.
The user shared progress pictures after over a year of hair loss treatment, using finasteride and topical minoxidil initially, then switching to dutasteride and oral minoxidil. A commenter complimented the results.
User shared progress using topical Finasteride 0.3% and Minoxidil 6% daily since January, noting some improvement and no side effects. Considering adding derma rolling for better results.
The conversation discusses hair regrowth treatments using finasteride, minoxidil pills, and topical minoxidil, with a focus on the use of a 1.5mm derma roller. Users advise caution with derma rolling, suggesting smaller needle sizes and longer intervals between sessions to avoid skin damage and systemic absorption of minoxidil.
Topical finasteride concentrations and application amounts are debated, with concerns that mainstream solutions may use arbitrary concentrations. A 0.25% solution with a specific application method is suggested as more appropriate than higher concentrations.